Previous studies have shown a diverse role for NPY in different types of cardiomyopathies, including an increase in NPY levels and effects on several pathological processes involved also in DOX-induced cardiotoxicity [11, 30, 53–56]. This evidence concerns the gene NPY and cardiomyopathy.